Clarivate Plc (NYSE:CLVT) Stock Holdings Increased by Invenomic Capital Management LP

Invenomic Capital Management LP raised its holdings in shares of Clarivate Plc (NYSE:CLVT - Free Report) by 11.3% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 6,585,707 shares of the company's stock after acquiring an additional 667,146 shares during the quarter. Clarivate makes up 1.6% of Invenomic Capital Management LP's investment portfolio, making the stock its 8th biggest holding. Invenomic Capital Management LP owned about 0.93% of Clarivate worth $33,455,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. GAMMA Investing LLC lifted its holdings in shares of Clarivate by 161.4% in the 4th quarter. GAMMA Investing LLC now owns 5,256 shares of the company's stock valued at $27,000 after purchasing an additional 3,245 shares during the last quarter. RPO LLC acquired a new stake in shares of Clarivate in the fourth quarter valued at approximately $55,000. Schonfeld Strategic Advisors LLC acquired a new position in shares of Clarivate in the 4th quarter valued at $56,000. Kathmere Capital Management LLC purchased a new stake in Clarivate in the 4th quarter valued at $58,000. Finally, Truist Financial Corp boosted its stake in Clarivate by 27.3% during the 4th quarter. Truist Financial Corp now owns 14,000 shares of the company's stock worth $71,000 after purchasing an additional 3,000 shares during the period. Hedge funds and other institutional investors own 85.72% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada reissued a "sector perform" rating and issued a $6.00 target price on shares of Clarivate in a report on Thursday, February 20th.

Clarivate Stock Performance

Shares of NYSE:CLVT traded up $0.07 during midday trading on Wednesday, hitting $4.51. The stock had a trading volume of 10,018,222 shares, compared to its average volume of 5,256,120. Clarivate Plc has a 1 year low of $3.04 and a 1 year high of $7.15. The company has a current ratio of 0.87, a quick ratio of 0.88 and a debt-to-equity ratio of 0.88. The stock has a 50 day moving average price of $3.88 and a two-hundred day moving average price of $4.72. The company has a market capitalization of $3.08 billion, a PE ratio of -4.70 and a beta of 1.49.

Clarivate (NYSE:CLVT - Get Free Report) last announced its quarterly earnings data on Tuesday, April 29th. The company reported $0.14 earnings per share for the quarter, beating analysts' consensus estimates of $0.12 by $0.02. Clarivate had a positive return on equity of 9.10% and a negative net margin of 24.90%. The company had revenue of $593.70 million for the quarter, compared to analyst estimates of $574.03 million. During the same quarter in the previous year, the company earned $0.14 EPS. The firm's revenue for the quarter was down 4.4% compared to the same quarter last year. As a group, equities analysts predict that Clarivate Plc will post 0.63 earnings per share for the current fiscal year.

Clarivate Profile

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.